综述:焦磷酸钙晶体沉积相关关节疾病的未满足需求与前进路径
焦磷酸钙(CPP)晶体沉积(CPPD)普遍存在,可与滑膜炎和关节损伤相关,主要影响老年人群且该人群快速增长。痛风、高尿酸血症和晶体相关疾病网络专家对CPPD未满足需求进行匿名调查并优先排序,作者据此提出基础与临床转化研究路径。
要点
- 需建立软骨细胞与软骨培养系统体外生成CPP晶体及转基因小动物CPPD模型以明确机制。
- 需国际共识统一CPPD命名与疾病表型分类,并更好利用先进影像和即时晶体分析。
- CPP晶体在骨关节炎和无症状关节中的临床影响仍是主要未解问题。
核心结论
- 作者认为CPPD基础与临床科学的上述进展现已可及,可带来更好的治疗。
研究设计与样本
- 作者对CPPD未满足需求进行匿名调查,由痛风、高尿酸血症和晶体相关疾病网络专家优先排序,并据结果提出研究路径。
主要发现
- CPPD普遍存在,可与滑膜炎和关节损伤相关,主要影响老年人群且该人群快速增长。
- CPPD在命名、表型分类、影像利用和即时晶体分析等方面存在不足。
- CPP晶体在骨关节炎和无症状关节中的临床影响仍是主要未解问题。
- 当前无法通过治疗限制或溶解晶体沉积并评估 consequent 临床结局,使上述问题更难解答。
关键数值与推荐
- 需软骨细胞与软骨培养系统体外生成CPP晶体及转基因小动物CPPD模型以明确机制并指导新疗法。
- 需国际共识统一CPPD命名与疾病表型分类、更好利用先进影像、务实的新型即时晶体分析检测CPP晶体。
- CPPD临床研究应定义关节CPPD造成实质损害的临床场景,并分析多样临床表型与人群。
- 临床试验应确定限制CPP晶体沉积及相关炎症的最佳治疗靶点,并包括关节内药物评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Calcium pyrophosphate (CPP) crystal deposition (CPPD) is prevalent and can be associated with synovitis and joint damage. The population of elderly persons predominantly affected by CPPD is growing rapidly. Since shortfalls exist in many aspects of CPPD, we conducted an anonymous survey of CPPD unmet needs, prioritized by experts from the Gout, Hyperuricemia and Crystal-Associated Disease Network. We provide our perspectives on the survey results, and we propose several CPPD basic and clinical translational research pathways. Chondrocyte and cartilage culture systems for generating CPP crystals in vitro and transgenic small animal CPPD models are needed to better define CPPD mechanism paradigms and help guide new therapies. CPPD recognition, clinical research, and care would be improved by international consensus on CPPD nomenclature and disease phenotype classification, better exploitation of advanced imaging, and pragmatic new point-of-care crystal analytic approaches for detecting CPP crystals. Clinical impacts of CPP crystals in osteoarthritis and in asymptomatic joints in elderly persons remain major unanswered questions that are rendered more difficult by current inability to therapeutically limit or dissolve the crystal deposits and assess the consequent clinical outcome. Going forward, CPPD clinical research studies should define clinical settings in which articular CPPD does substantial harm and should include analyses of diverse clinical phenotypes and populations. Clinical trials should identify the best therapeutic targets to limit CPP crystal deposition and associated inflammation and should include assessment of intraarticular agents. Our perspective is that such advances in basic and clinical science in CPPD are now within reach and can lead to better treatments for this disorder.
引用
- Abhishek A, Neogi T, Choi H, et al. Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition. Arthritis Rheumatol. 2018. PMID: 29609209. doi:10.1002/art.40517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。